Premium
Zero Withdrawal Anesthetic for All Finfish and Shellfish
Author(s) -
Schnick Rosalie “Roz”
Publication year - 2006
Publication title -
fisheries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 79
eISSN - 1548-8446
pISSN - 0363-2415
DOI - 10.1577/1548-8446(2006)31[122:zwafaf]2.0.co;2
Subject(s) - confusion , aquaculture , zero tolerance , fishery , anesthetic , business , fisheries management , stakeholder , fish <actinopterygii> , medicine , political science , fishing , anesthesia , public relations , psychology , biology , law , psychoanalysis
The critical need in the United States for a zero withdrawal time anesthetic or sedative is widely recognized by fish culturists and fishery managers for both public and private aquaculture and fisheries management. There has also been confusion concerning whether such drugs as clove oil or eugenol are appropriate to use as anesthetics in aquaculture and fisheries. Recently, the American Fisheries Society was asked to help resolve this confusion by establishing a dialogue among stakeholders. A consortium of stakeholders, including a proactive pharmaceutical sponsor, has made a serious effort to gain a New Animal Drug Application approval of a potential zero withdrawal anesthetic called AQUI‐S®. The present article is an attempt to address the circumstances related to an approval for a zero withdrawal anesthetic to include (1) need, (2) stakeholder groups, (3) candidate anesthetics, and (4) approval effort on candidate AQUI‐S®.